MY139442A - Novel use of peptide compounds for treating dyskinesia - Google Patents

Novel use of peptide compounds for treating dyskinesia

Info

Publication number
MY139442A
MY139442A MYPI20053160A MY139442A MY 139442 A MY139442 A MY 139442A MY PI20053160 A MYPI20053160 A MY PI20053160A MY 139442 A MY139442 A MY 139442A
Authority
MY
Malaysia
Prior art keywords
peptide compounds
novel use
treating dyskinesia
treating
dyskinesia
Prior art date
Application number
Inventor
Stoehr Thomas
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Priority to MYPI20053160 priority Critical patent/MY139442A/en
Publication of MY139442A publication Critical patent/MY139442A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

THE PRESENT INVENTION IS DIRECTED TO THE USE OF A CLASS OF PEPTIDE COMPOUNDS FOR TREATING PRIMARY OR/AND SECONDARY DYSKINESIAS SUCH AS TARDIVE DYSKINESIA.
MYPI20053160 2005-07-11 2005-07-11 Novel use of peptide compounds for treating dyskinesia MY139442A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20053160 MY139442A (en) 2005-07-11 2005-07-11 Novel use of peptide compounds for treating dyskinesia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20053160 MY139442A (en) 2005-07-11 2005-07-11 Novel use of peptide compounds for treating dyskinesia

Publications (1)

Publication Number Publication Date
MY139442A true MY139442A (en) 2009-10-30

Family

ID=45756814

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20053160 MY139442A (en) 2005-07-11 2005-07-11 Novel use of peptide compounds for treating dyskinesia

Country Status (1)

Country Link
MY (1) MY139442A (en)

Similar Documents

Publication Publication Date Title
UA86808C2 (en) Novel use of peptide compounds for treating dyskinesia
MX2008002293A (en) Novel use of peptide compounds for treating muscle pain.
UA88166C2 (en) Use of peptide compounds for treating essential tremor and other tremor syndromes
TW200640924A (en) VEGF-R2 inhibitors and methods
TW200701982A (en) Novel use of peptide compounds for treating pain in trigeminal neuralgia
MX2008007808A (en) Rifamycin analogs and uses thereof.
CR9244A (en) AMINO-IMIDAZOLONES FOR THE INHIBITION OF ß-SECRETASA
TW200800963A (en) Chemical compounds
HK1113352A1 (en) Chemical compounds
PT1853588E (en) Chemical compounds
PT1761520E (en) Kinase inhibitors
MX2007008137A (en) Triazolophthalazines.
MX2009006536A (en) Organic compounds and their uses.
TW200602029A (en) Inhibitors of IAP
SG161310A1 (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
ZA200701137B (en) Triazolophthalazines
MY153766A (en) Derivatised proline containing peptide organic compounds as protease inhibitors
TW200630367A (en) Substituted adenines and the uses thereof
MX337083B (en) Pesticides and uses thereof.
UA85505C2 (en) Kinase inhibitors
CL2007002384A1 (en) Use of compounds derived from 2,5-dihydroxybenzene for the treatment of psoriasis.
TW200738244A (en) 20-Alkyl, gemini vitamin D3 compounds and methods of use thereof
UA96269C2 (en) Cysteine protease inhibitors and their therapeutic applications
TW200621718A (en) Novel co-crystals
MY139442A (en) Novel use of peptide compounds for treating dyskinesia